Neurexins

Genome Biology

Volumn 14, Issue 9, 2013, Pages

  Reissner, Carsten ^a   Runkel, Fabian ^a   Missler, Markus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUREXIN; NEUROLIGIN; CEREBELLIN; ISOPROTEIN; LRRTM1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; NEUREXIN IBETA; NEUROLIGIN 1; NRXN1 PROTEIN, HUMAN;

ARTICLE; CAENORHABDITIS ELEGANS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DROSOPHILA MELANOGASTER; GENE; HISTORY; HUMAN; MENTAL DISEASE; MOLECULAR EVOLUTION; MOLECULAR PATHOLOGY; NEUREXIN GENE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; ALTERNATIVE RNA SPLICING; AUTISM; CHEMICAL STRUCTURE; CHEMISTRY; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

ALTERNATIVE SPLICING; AUTISTIC DISORDER; CELL ADHESION MOLECULES, NEURONAL; GENE DOSAGE; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; MODELS, MOLECULAR; MUTATION; NERVE TISSUE PROTEINS; NEURONS; PRESYNAPTIC TERMINALS; PROTEIN ISOFORMS; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 84884691301     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2013-14-9-213     Document Type: Article

References (133)

1. Ullrich B, Ushkaryov YA, Südhof TC: Cartography of neurexins: more than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons. Neuron 1995, 14:497-507.
2. Ushkaryov YA, Hata Y, Ichtchenko K, Moomaw C, Afendis S, Slaughter CA, Südhof TC: Conserved domain structure of beta-neurexins. Unusual cleaved signal sequences in receptor-like neuronal cell-surface proteins. J Biol Chem 1994, 269:11987-11992.
3. Ushkaryov YA, Petrenko AG, Geppert M, Südhof TC: Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science 1992, 257:50-56.
4. Etherton MR, Blaiss CA, Powell CM, Südhof TC: Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci U S A 2009, 106:17998-18003.
5. Kattenstroth G, Tantalaki E, Südhof TC, Gottmann K, Missler M: Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. Proc Natl Acad Sci U S A 2004, 101:2607-2612.
6. 2+ channels to synaptic vesicle exocytosis. Nature 2003, 423:939-948.
7. Sons MS, Busche N, Strenzke N, Moser T, Ernsberger U, Mooren FC, Zhang W, Ahmad M, Steffens H, Schomburg ED, Plomp JJ, Missler M: alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction. Neuroscience 2006, 138:433-446.
8. Zhang C, Atasoy D, Arac D, Yang X, Fuccillo MV, Robison AJ, Ko J, Brunger AT, Südhof TC: Neurexins physically and functionally interact with GABA (A) receptors. Neuron 2010, 66:403-416.
9. Chubykin AA, Atasoy D, Etherton MR, Brose N, Kavalali ET, Gibson JR, Südhof TC: Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 2007, 54:919-931.
10. Dean C, Scholl FG, Choih J, DeMaria S, Berger J, Isacoff E, Scheiffele P: Neurexin mediates the assembly of presynaptic terminals. Nat Neurosci 2003, 6:708-716.
11. Dudanova I, Tabuchi K, Rohlmann A, Südhof TC, Missler M: Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation. J Comp Neurol 2007, 502:261-274.
12. Graf ER, Zhang X, Jin SX, Linhoff MW, Craig AM: Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119:1013-1026.
13. Nam CI, Chen L: Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter. Proc Natl Acad Sci U S A 2005, 102:6137-6142.
14. Scheiffele P, Fan J, Choih J, Fetter R, Serafini T: Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000, 101:657-669.
15. Boucard AA, Chubykin AA, Comoletti D, Taylor P, Südhof TC: A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha-and beta-neurexins. Neuron 2005, 48:229-236.
16. Ichtchenko K, Hata Y, Nguyen T, Ullrich B, Missler M, Moomaw C, Südhof TC: Neuroligin 1: a splice site-specific ligand for beta-neurexins. Cell 1995, 81:435-443.
17. Missler M, Hammer RE, Südhof TC: Neurexophilin binding to alphaneurexins. A single LNS domain functions as an independently folding ligand-binding unit. J Biol Chem 1998, 273:34716-34723.
18. Missler M, Südhof TC: Neurexophilins form a conserved family of neuropeptide-like glycoproteins. J Neurosci 1998, 18:3630-3638.
19. Petrenko AG, Ullrich B, Missler M, Krasnoperov V, Rosahl TW, Südhof TC: Structure and evolution of neurexophilin. J Neurosci 1996, 16:4360-4369.
20. Sugita S, Saito F, Tang J, Satz J, Campbell K, Südhof TC: A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol 2001, 154:435-445.
21. de Wit J, Sylwestrak E, O'Sullivan ML, Otto S, Tiglio K, Savas JN, Yates JR 3rd, Comoletti D, Taylor P, Ghosh A: LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation. Neuron 2009, 64:799-806.
22. Ko J, Fuccillo MV, Malenka RC, Südhof TC: LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation. Neuron 2009, 64:791-798.
23. Matsuda K, Yuzaki M: Cbln family proteins promote synapse formation by regulating distinct neurexin signaling pathways in various brain regions. Eur J Neurosci 2011, 33:1447-1461.
24. Uemura T, Lee SJ, Yasumura M, Takeuchi T, Yoshida T, Ra M, Taguchi R, Sakimura K, Mishina M: Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell 2010, 141:1068-1079.
25. Südhof TC: Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
26. Bourgeron T: A synaptic trek to autism. Curr Opin Neurobiol 2009, 19:231-234.
27. Reichelt AC, Rodgers RJ, Clapcote SJ: The role of neurexins in schizophrenia and autistic spectrum disorder. Neuropharmacology 2012, 62:1519-1526.
28. Ushkaryov YA, Südhof TC: Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms. Proc Natl Acad Sci U S A 1993, 90:6410-6414.
29. Missler M, Südhof TC: Neurexins: three genes and 1001 products. Trends Genet 1998, 14:20-26.
30. Tabuchi K, Südhof TC: Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 2002, 79:849-859.
31. Rowen L, Young J, Birditt B, Kaur A, Madan A, Philipps DL, Qin S, Minx P, Wilson RK, Hood L, Graveley BR: Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics 2002, 79:587-597.
32. Biswas S, Russell RJ, Jackson CJ, Vidovic M, Ganeshina O, Oakeshott JG, Claudianos C: Bridging the synaptic gap: neuroligins and neurexin I in Apis mellifera. PLoS One 2008, 3:e3542.
33. Haklai-Topper L, Soutschek J, Sabanay H, Scheel J, Hobert O, Peles E: The neurexin superfamily of Caenorhabditis elegans. Gene Expr Patterns 2011, 11:144-150.
34. Rissone A, Monopoli M, Beltrame M, Bussolino F, Cotelli F, Arese M: Comparative genome analysis of the neurexin gene family in Danio rerio: insights into their functions and evolution. Mol Biol Evol 2007, 24:236-252.
35. Zeng X, Sun M, Liu L, Chen F, Wei L, Xie W: Neurexin-1 is required for synapse formation and larvae associative learning in Drosophila. FEBS Lett 2007, 581:2509-2516.
36. Keren H, Lev-Maor G, Ast G: Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet 2010, 11:345-355.
37. 2+ channels. J Neurosci 2005, 25:4330-4342.
38. Fairless R, Masius H, Rohlmann A, Heupel K, Ahmad M, Reissner C, Dresbach T, Missler M: Polarized targeting of neurexins to synapses is regulated by their C-terminal sequences. J Neurosci 2008, 28:12969-12981.
39. Rudenko G, Hohenester E, Muller YA: LG/LNS domains: multiple functions-one business end? Trends Biochem Sci 2001, 26:363-368.
40. 2+ interactions. Neuron 2007, 56:992-1003.
41. Chen X, Liu H, Shim AH, Focia PJ, He X: Structural basis for synaptic adhesion mediated by neuroligin-neurexin interactions. Nat Struct Mol Biol 2008, 15:50-56.
42. Fabrichny IP, Leone P, Sulzenbacher G, Comoletti D, Miller MT, Taylor P, Bourne Y, Marchot P: Structural analysis of the synaptic protein neuroligin and its beta-neurexin complex: determinants for folding and cell adhesion. Neuron 2007, 56:979-991.
43. Rudenko G, Nguyen T, Chelliah Y, Südhof TC, Deisenhofer J: The structure of the ligand-binding domain of neurexin Ibeta: regulation of LNS domain function by alternative splicing. Cell 1999, 99:93-101.
44. Wizemann H, Garbe JH, Friedrich MV, Timpl R, Sasaki T, Hohenester E: Distinct requirements for heparin and alpha-dystroglycan binding revealed by structure-based mutagenesis of the laminin alpha2 LG4-LG5 domain pair. J Mol Biol 2003, 332:635-642.
45. Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, Madson M, Oldstone MB, Schachter H, Wells L, Campbell KP: O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 2010, 327:88-92.
46. Reissner C, Klose M, Fairless R, Missler M: Mutational analysis of the neurexin/neuroligin complex reveals essential and regulatory components. Proc Natl Acad Sci U S A 2008, 105:15124-15129.
47. Striegel AR, Biela LM, Evans CS, Wang Z, Delehoy JB, Sutton RB, Chapman ER, Reist NE: Calcium binding by synaptotagmin's C2A domain is an essential element of the electrostatic switch that triggers synchronous synaptic transmission. J Neurosci 2012, 32:1253-1260.
48. Siddiqui TJ, Pancaroglu R, Kang Y, Rooyakkers A, Craig AM: LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J Neurosci 2010, 30:7495-7506.
49. Ichtchenko K, Nguyen T, Südhof TC: Structures, alternative splicing, and neurexin binding of multiple neuroligins. J Biol Chem 1996, 271:2676-2682.
50. Bolliger MF, Frei K, Winterhalter KH, Gloor SM: Identification of a novel neuroligin in humans which binds to PSD-95 and has a widespread expression. Biochem J 2001, 356:581-588.
51. Koehnke J, Jin X, Budreck EC, Posy S, Scheiffele P, Honig B, Shapiro L: Crystal structure of the extracellular cholinesterase-like domain from neuroligin-2. Proc Natl Acad Sci U S A 2008, 105:1873-1878.
52. Hussain NK, Sheng M: Neuroscience. Making synapses: a balancing act. Science 2005, 307:1207-1208.
53. Chih B, Gollan L, Scheiffele P: Alternative splicing controls selective transsynaptic interactions of the neuroligin-neurexin complex. Neuron 2006, 51:171-178.
54. Koehnke J, Katsamba PS, Ahlsen G, Bahna F, Vendome J, Honig B, Shapiro L, Jin X: Splice form dependence of beta-neurexin/neuroligin binding interactions. Neuron 2010, 67:61-74.
55. Miller MT, Mileni M, Comoletti D, Stevens RC, Harel M, Taylor P: The crystal structure of the alpha-neurexin-1 extracellular region reveals a hinge point for mediating synaptic adhesion and function. Structure 2011, 19:767-778.
56. Leone P, Comoletti D, Ferracci G, Conrod S, Garcia SU, Taylor P, Bourne Y, Marchot P: Structural insights into the exquisite selectivity of neurexin/neuroligin synaptic interactions. EMBO J 2010, 29:2461-2471.
57. Shen KC, Kuczynska DA, Wu IJ, Murray BH, Sheckler LR, Rudenko G: Regulation of neurexin 1beta tertiary structure and ligand binding through alternative splicing. Structure 2008, 16:422-431.
58. Comoletti D, Flynn RE, Boucard AA, Demeler B, Schirf V, Shi J, Jennings LL, Newlin HR, Südhof TC, Taylor P: Gene selection, alternative splicing, and post-translational processing regulate neuroligin selectivity for betaneurexins. Biochemistry (Mosc) 2006, 45:12816-12827.
59. Tanaka H, Nogi T, Yasui N, Iwasaki K, Takagi J: Structural basis for variantspecific neuroligin-binding by alpha-neurexin. PLoS ONE 2011, 6:e19411.
60. Chen F, Venugopal V, Murray B, Rudenko G: The structure of neurexin 1alpha reveals features promoting a role as synaptic organizer. Structure 2011, 19:779-789.
61. Koehnke J, Jin X, Trbovic N, Katsamba PS, Brasch J, Ahlsen G, Scheiffele P, Honig B, Palmer AG 3rd, Shapiro L: Crystal structures of beta-neurexin 1 and beta-neurexin 2 ectodomains and dynamics of splice insertion sequence 4. Structure 2008, 16:410-421.
62. Comoletti D, Miller MT, Jeffries CM, Wilson J, Demeler B, Taylor P, Trewhella J, Nakagawa T: The macromolecular architecture of extracellular domain of alphaNRXN1: domain organization, flexibility, and insights into transsynaptic disposition. Structure 2010, 18:1044-1053.
63. Reissner C, Missler M: Unveiled alpha-neurexins take center stage. Structure 2011, 19:749-750.
64. Tanaka H, Miyazaki N, Matoba K, Nogi T, Iwasaki K, Takagi J: Higher-order architecture of cell adhesion mediated by polymorphic synaptic adhesion molecules neurexin and neuroligin. Cell Rep 2012, 2:101-110.
65. Geppert M, Khvotchev M, Krasnoperov V, Goda Y, Missler M, Hammer RE, Ichtchenko K, Petrenko AG, Südhof TC: Neurexin I alpha is a major alphalatrotoxin receptor that cooperates in alpha-latrotoxin action. J Biol Chem 1998, 273:1705-1710.
66. Taniguchi H, Gollan L, Scholl FG, Mahadomrongkul V, Dobler E, Limthong N, Peck M, Aoki C, Scheiffele P: Silencing of neuroligin function by postsynaptic neurexins. J Neurosci 2007, 27:2815-2824.
67. Püschel AW, Betz H: Neurexins are differentially expressed in the embryonic nervous system of mice. J Neurosci 1995, 15:2849-2856.
68. Patzke H, Ernsberger U: Expression of neurexin Ialpha splice variants in sympathetic neurons: selective changes during differentiation and in response to neurotrophins. Mol Cell Neurosci 2000, 15:561-572.
69. Berninghausen O, Rahman MA, Silva JP, Davletov B, Hopkins C, Ushkaryov YA: Neurexin Ibeta and neuroligin are localized on opposite membranes in mature central synapses. J Neurochem 2007, 103:1855-1863.
70. Yasumura M, Yoshida T, Lee SJ, Uemura T, Joo JY, Mishina M: Glutamate receptor delta1 induces preferentially inhibitory presynaptic differentiation of cortical neurons by interacting with neurexins through cerebellin precursor protein subtypes. J Neurochem 2012, 121:705-716.
71. Shapiro-Reznik M, Jilg A, Lerner H, Earnest DJ, Zisapel N: Diurnal rhythms in neurexins transcripts and inhibitory/excitatory synapse scaffold proteins in the biological clock. PLoS One 2012, 7:e37894.
72. Iijima T, Wu K, Witte H, Hanno-Iijima Y, Glatter T, Richard S, Scheiffele P: SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1. Cell 2011, 147:1601-1614.
73. 2+-dependent splicing of neurexin IIalpha. Biochem Biophys Res Commun 2007, 352:226-230.
74. Rozic G, Lupowitz Z, Piontkewitz Y, Zisapel N: Dynamic changes in neurexins' alternative splicing: role of Rho-associated protein kinases and relevance to memory formation. PLoS One 2011, 6:e18579.
75. Kang Y, Zhang X, Dobie F, Wu H, Craig AM: Induction of GABAergic postsynaptic differentiation by alpha-neurexins. J Biol Chem 2008, 283:2323-2334.
76. 2+-triggered exocytosis of secretory granules. J Neurosci 2006, 26:10599-10613.
77. Hata Y, Butz S, Südhof TC: CASK: a novel dlg/PSD95 homolog with an Nterminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. J Neurosci 1996, 16:2488-2494.
78. Biederer T, Südhof TC: Mints as adaptors. Direct binding to neurexins and recruitment of munc18. J Biol Chem 2000, 275:39803-39806.
79. Maximov A, Südhof TC, Bezprozvanny I: Association of neuronal calcium channels with modular adaptor proteins. J Biol Chem 1999, 274:24453-24456.
80. 2+ channel complex. FEBS Lett 1993, 326:255-260.
81. Atasoy D, Schoch S, Ho A, Nadasy KA, Liu X, Zhang W, Mukherjee K, Nosyreva ED, Fernandez-Chacon R, Missler M, Kavalali ET, Südhof TC: Deletion of CASK in mice is lethal and impairs synaptic function. Proc Natl Acad Sci U S A 2007, 104:2525-2530.
82. Ho A, Liu X, Südhof TC: Deletion of Mint proteins decreases amyloid production in transgenic mouse models of Alzheimer's disease. J Neurosci 2008, 28:14392-14400.
83. 2+ channels to presynaptic active zones via a direct PDZ-domain interaction. Cell 2011, 144:282-295.
84. Hoppa MB, Lana B, Margas W, Dolphin AC, Ryan TA: alpha2delta expression sets presynaptic calcium channel abundance and release probability. Nature 2012, 486:122-125.
85. Di Biase V, Tuluc P, Campiglio M, Obermair GJ, Heine M, Flucher BE: Surface traffic of dendritic CaV1.2 calcium channels in hippocampal neurons. J Neurosci 2011, 31:13682-13694.
86. Chih B, Engelman H, Scheiffele P: Control of excitatory and inhibitory synapse formation by neuroligins. Science 2005, 307:1324-1328.
87. Poulopoulos A, Soykan T, Tuffy LP, Hammer M, Varoqueaux F, Brose N: Homodimerization and isoform-specific heterodimerization of neuroligins. Biochem J 2012, 446:321-330.
88. Varoqueaux F, Aramuni G, Rawson RL, Mohrmann R, Missler M, Gottmann K, Zhang W, Südhof TC, Brose N: Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
89. Lee H, Dean C, Isacoff E: Alternative splicing of neuroligin regulates the rate of presynaptic differentiation. J Neurosci 2010, 30:11435-11446.
90. Futai K, Kim MJ, Hashikawa T, Scheiffele P, Sheng M, Hayashi Y: Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin. Nat Neurosci 2007, 10:186-195.
91. Varoqueaux F, Jamain S, Brose N: Neuroligin 2 is exclusively localized to inhibitory synapses. Eur J Cell Biol 2004, 83:449-456.
92. Fu Y, Huang ZJ: Differential dynamics and activity-dependent regulation of alpha-and beta-neurexins at developing GABAergic synapses. Proc Natl Acad Sci U S A 2010, 107:22699-22704.
93. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Südhof TC: A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
94. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY: Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
95. Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O'Shea DJ, Sohal VS, Goshen I, Finkelstein J, Paz JT, Stehfest K, Fudim R, Ramakrishnan C, Huguenard JR, Hegemann P, Deisseroth K: Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477:171-178.
96. Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, Baird G, Bolshakova N, Bolte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Casey J, Conroy J, Correia C, Corsello C, Crawford EL, de Jonge M, Delorme R, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Gilbert J, Gillberg C, Glessner JT, Green A, et al: Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet 2012, 21:4781-4792.
97. Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y, Lally E, Weiss LA, Najm J, Kutsche K, Descartes M, Holt L, Braddock S, Troxell R, Kaplan L, Volkmar F, Klin A, Tsatsanis K, Harris DJ, Noens I, Pauls DL, Daly MJ, MacDonald ME, Morton CC, Quade BJ, Gusella JF: Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008, 82:199-207.
98. Kirov G, Rujescu D, Ingason A, Collier DA, O'Donovan MC, Owen MJ: Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull 2009, 35:851-854.
99. Ching MS, Shen Y, Tan WH, Jeste SS, Morrow EM, Chen X, Mukaddes NM, Yoo SY, Hanson E, Hundley R, Austin C, Becker RE, Berry GT, Driscoll K, Engle EC, Friedman S, Gusella JF, Hisama FM, Irons MB, Lafiosca T, LeClair E, Miller DT, Neessen M, Picker JD, Rappaport L, Rooney CM, Sarco DP, Stoler JM, Walsh CA, Wolff RR, et al: Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:937-947.
100. Vaags AK, Lionel AC, Sato D, Goodenberger M, Stein QP, Curran S, Ogilvie C, Ahn JW, Drmic I, Senman L, Chrysler C, Thompson A, Russell C, Prasad A, Walker S, Pinto D, Marshall CR, Stavropoulos DJ, Zwaigenbaum L, Fernandez BA, Fombonne E, Bolton PF, Collier DA, Hodge JC, Roberts W, Szatmari P, Scherer SW: Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet 2012, 90:133-141.
101. Feng J, Schroer R, Yan J, Song W, Yang C, Bockholt A, Cook EH Jr, Skinner C, Schwartz CE, Sommer SS: High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 2006, 409:10-13.
102. Ey E, Leblond CS, Bourgeron T: Behavioral profiles of mouse models for autism spectrum disorders. Autism Res 2011, 4:5-16.
103. Doherty JL, O'Donovan MC, Owen MJ: Recent genomic advances in schizophrenia. Clin Genet 2012, 81:103-109.
104. Levinson DF, Shi J, Wang K, Oh S, Riley B, Pulver AE, Wildenauer DB, Laurent C, Mowry BJ, Gejman PV, Owen MJ, Kendler KS, Nestadt G, Schwab SG, Mallet J, Nertney D, Sanders AR, Williams NM, Wormley B, Lasseter VK, Albus M, Godard-Bauché S, Alexander M, Duan J, O'Donovan MC, Walsh D, O'Neill A, Papadimitriou GN, Dikeos D, Maier W, et al: Genome-wide association study of multiplex schizophrenia pedigrees. Am J Psychiatry 2012, 169:963-973.
105. Stoltenberg SF, Lehmann MK, Christ CC, Hersrud SL, Davies GE: Associations among types of impulsivity, substance use problems and neurexin-3 polymorphisms. Drug Alcohol Depend 2011, 119:e31-e38.
106. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T: Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003, 34:27-29.
107. Etherton M, Foldy C, Sharma M, Tabuchi K, Liu X, Shamloo M, Malenka RC, Südhof TC: Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc Natl Acad Sci U S A 2011, 108:13764-13769.
108. Etherton MR, Tabuchi K, Sharma M, Ko J, Südhof TC: An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J 2011, 30:2908-2919.
109. Arons MH, Thynne CJ, Grabrucker AM, Li D, Schoen M, Cheyne JE, Boeckers TM, Montgomery JM, Garner CC: Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling. J Neurosci 2012, 32:14966-14978.
110. Chih B, Afridi SK, Clark L, Scheiffele P: Disorder-associated mutations lead to functional inactivation of neuroligins. Hum Mol Genet 2004, 13:1471-1477.
111. Comoletti D, De Jaco A, Jennings LL, Flynn RE, Gaietta G, Tsigelny I, Ellisman MH, Taylor P: The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. J Neurosci 2004, 24:4889-4893.
112. Sun M, Xing G, Yuan L, Gan G, Knight D, With SI, He C, Han J, Zeng X, Fang M, Boulianne GL, Xie W: Neuroligin 2 is required for synapse development and function at the Drosophila neuromuscular junction. J Neurosci 2011, 31:687-699.
113. Feinberg EH, Vanhoven MK, Bendesky A, Wang G, Fetter RD, Shen K, Bargmann CI: GFP Reconstitution Across Synaptic Partners (GRASP) defines cell contacts and synapses in living nervous systems. Neuron 2008, 57:353-363.
114. Graf ER, Kang Y, Hauner AM, Craig AM: Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain. J Neurosci 2006, 26:4256-4265.
115. Banovic D, Khorramshahi O, Owald D, Wichmann C, Riedt T, Fouquet W, Tian R, Sigrist SJ, Aberle H: Drosophila neuroligin 1 promotes growth and postsynaptic differentiation at glutamatergic neuromuscular junctions. Neuron 2010, 66:724-738.
116. Hu Z, Hom S, Kudze T, Tong XJ, Choi S, Aramuni G, Zhang W, Kaplan JM: Neurexin and neuroligin mediate retrograde synaptic inhibition in C. elegans. Science 2012, 337:980-984.
117. Li C, Han D, Zhang F, Zhou C, Yu HM, Zhang GY: Preconditioning ischemia attenuates increased neurexin-neuroligin1-PSD-95 interaction after transient cerebral ischemia in rat hippocampus. Neurosci Lett 2007, 426:192-197.
118. Knight D, Xie W, Boulianne GL: Neurexins and neuroligins: recent insights from invertebrates. Mol Neurobiol 2011, 44:426-440.
119. Owald D, Khorramshahi O, Gupta VK, Banovic D, Depner H, Fouquet W, Wichmann C, Mertel S, Eimer S, Reynolds E, Holt M, Aberle H, Sigrist SJ: Cooperation of Syd-1 with Neurexin synchronizes pre-with postsynaptic assembly. Nat Neurosci 2012, 15:1219-1226.
120. Bottos A, Rissone A, Bussolino F, Arese M: Neurexins and neuroligins: synapses look out of the nervous system. Cell Mol Life Sci 2011, 68:2655-2666.
121. Occhi G, Rampazzo A, Beffagna G, Antonio Danieli G: Identification and characterization of heart-specific splicing of human neurexin 3 mRNA (NRXN3). Biochem Biophys Res Commun 2002, 298:151-155.
122. Mosedale M, Egodage S, Calma RC, Chi NW, Chessler SD: Neurexin-1alpha contributes to insulin-containing secretory granule docking. J Biol Chem 2012, 287:6350-6361.
123. Suckow AT, Comoletti D, Waldrop MA, Mosedale M, Egodage S, Taylor P, Chessler SD: Expression of neurexin, neuroligin, and their cytoplasmic binding partners in the pancreatic beta-cells and the involvement of neuroligin in insulin secretion. Endocrinology 2008, 149:6006-6017.
124. Suckow AT, Zhang C, Egodage S, Comoletti D, Taylor P, Miller MT, Sweet IR, Chessler SD: Transcellular neuroligin-2 interactions enhance insulin secretion and are integral to pancreatic beta cell function. J Biol Chem 2012, 287:19816-19826.
125. Bottos A, Destro E, Rissone A, Graziano S, Cordara G, Assenzio B, Cera MR, Mascia L, Bussolino F, Arese M: The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions. Proc Natl Acad Sci U S A 2009, 106:20782-20787.
126. Aoto J, Martinelli DC, Malenka RC, Tabuchi K, Südhof TC: Presynaptic neurexin-3 alternative splicing trans-synaptically controls postsynaptic AMPA receptor trafficking. Cell 2013, 154:75-88.
127. Gjorlund MD, Nielsen J, Pankratova S, Li S, Korshunova I, Bock E, Berezin V: Neuroligin-1 induces neurite outgrowth through interaction with neurexin-1beta and activation of fibroblast growth factor receptor-1. FASEB J 2012, 26:4174-4186.
128. Beglopoulos V, Montag-Sallaz M, Rohlmann A, Piechotta K, Ahmad M, Montag D, Missler M: Neurexophilin 3 is highly localized in cortical and cerebellar regions and is functionally important for sensorimotor gating and motor coordination. Mol Cell Biol 2005, 25:7278-7288.
129. Owen MJ, Williams HJ, O'Donovan MC: Schizophrenia genetics: advancing on two fronts. Curr Opin Genet Dev 2009, 19:266-270.
130. Zhou H, Xu Y, Yang Y, Huang A, Wu J, Shi Y: Solution structure of AF-6 PDZ domain and its interaction with the C-terminal peptides from Neurexin and Bcr. J Biol Chem 2005, 280:13841-13847.
131. Clarris HJ, McKeown S, Key B: Expression of neurexin ligands, the neuroligins and the neurexophilins, in the developing and adult rodent olfactory bulb. Int J Dev Biol 2002, 46:649-652.
132. Brodskii LI, Ivanov VV, Kalaidzidis LL, Leontovich AM, Nikolaev VK, Feranchuk SI, Drachev VA: GeneBee-NET: an internet based server for biopolymer structure analysis. Biokhimiia 1995, 60:1221-1230.
133. GenBank. [http://ncbi.nlm.nih.gov/genbank/].